Fig. 2
Survival comparison of metronomic capecitabine adjuvant chemotherapy in patients with LA-NPC (A: OS, B: LRRFS, C: PFS, D: DMFS)
Fig. 2 | BMC Immunology
Survival comparison of metronomic capecitabine adjuvant chemotherapy in patients with LA-NPC (A: OS, B: LRRFS, C: PFS, D: DMFS)